Total marketcap
Total volume
BTC 49.67%     ETH 16.68%

Gilead Sciences GILD Stock

77.65 USD {{ price }} 1.370761% {{change_pct}}%
Market Cap
96.76B USD
LOW - HIGH [24H]
76.2 - 77.66 USD
5.28M USD
{{ volume }}
P/E Ratio
Earnings per share
4.67 USD

Gilead Sciences Price Chart

Gilead Sciences GILD Financial and Trading Overview

Gilead Sciences stock price 77.65 USD
Previous Close 77.95 USD
Open 78.28 USD
Bid 0 USD x 2200
Ask 0 USD x 800
Day's Range 77.78 - 79.01 USD
52 Week Range 57.29 - 89.74 USD
Volume 6.51M USD
Avg. Volume 5.51M USD
Market Cap 98.54B USD
Beta (5Y Monthly) 0.40669
PE Ratio (TTM) 17.873302
EPS (TTM) 4.67 USD
Forward Dividend & Yield 3 (3.85%)
Ex-Dividend Date June 14, 2023
1y Target Est 91.38 USD

GILD Valuation Measures

Enterprise Value 115.89B USD
Trailing P/E 17.873302
Forward P/E 10.987482
PEG Ratio (5 yr expected) 5
Price/Sales (ttm) 3.6438506
Price/Book (mrq) 4.6953936
Enterprise Value/Revenue 4.286
Enterprise Value/EBITDA 9.302

Trading Information

Gilead Sciences Stock Price History

Beta (5Y Monthly) 0.40669
52-Week Change 34.97%
S&P500 52-Week Change 20.43%
52 Week High 89.74 USD
52 Week Low 57.29 USD
50-Day Moving Average 80.16 USD
200-Day Moving Average 78.87 USD

GILD Share Statistics

Avg. Volume (3 month) 5.51M USD
Avg. Daily Volume (10-Days) 6.15M USD
Shares Outstanding 1.25B
Float 1.25B
Short Ratio 2.96
% Held by Insiders 0.096%
% Held by Institutions 85.97%
Shares Short 15.28M
Short % of Float 1.37%
Short % of Shares Outstanding 1.23%

Dividends & Splits

Trailing Annual Dividend Rate 2.94
Trailing Annual Dividend Yield 3.77%
5 Year Average Dividend Yield 386.00%
Payout Ratio 0.6652
Last Split Factor 2:1

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023


Profit Margin 20.64%
Operating Margin (ttm) 37.86%
Gross Margin 79.16%
EBITDA Margin 46.07%

Management Effectiveness

Return on Assets (ttm) 10.24%
Return on Equity (ttm) 27.11%

Income Statement

Revenue (ttm) 27.04B USD
Revenue Per Share (ttm) 21.58 USD
Quarterly Revenue Growth (yoy) -3.59%
Gross Profit (ttm) 21.62B USD
Net Income Avi to Common (ttm) 5.58B USD
Diluted EPS (ttm) 4.42
Quarterly Earnings Growth (yoy) 5215.80%

Balance Sheet

Total Cash (mrq) 6.52B USD
Total Cash Per Share (mrq) 5.23 USD
Total Debt (mrq) 25.24B USD
Total Debt/Equity (mrq) 120.54 USD
Current Ratio (mrq) 1.278
Book Value Per Share (mrq) 16.825

Cash Flow Statement

Operating Cash Flow (ttm) 8.98B USD
Levered Free Cash Flow (ttm) 8.51B USD

Profile of Gilead Sciences

Country United States
State CA
City Foster City
Address 333 Lakeside Drive
ZIP 94404
Phone 650 574 3000
Website https://www.gilead.com
Industry Drug Manufacturers-General
Sector(s) Healthcare
Full Time Employees 17000

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Merck & Co, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.

Q&A For Gilead Sciences Stock

What is a current GILD stock price?

Gilead Sciences GILD stock price today per share is 77.65 USD.

How to purchase Gilead Sciences stock?

You can buy GILD shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Gilead Sciences?

The stock symbol or ticker of Gilead Sciences is GILD.

Which industry does the Gilead Sciences company belong to?

The Gilead Sciences industry is Drug Manufacturers-General.

How many shares does Gilead Sciences have in circulation?

The max supply of Gilead Sciences shares is 1.25B.

What is Gilead Sciences Price to Earnings Ratio (PE Ratio)?

Gilead Sciences PE Ratio is 16.62740900 now.

What was Gilead Sciences earnings per share over the trailing 12 months (TTM)?

Gilead Sciences EPS is 4.67 USD over the trailing 12 months.

Which sector does the Gilead Sciences company belong to?

The Gilead Sciences sector is Healthcare.

Gilead Sciences GILD included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 14305.03 USD
5.09B USD 14135.01 USD 14311.95 USD 5.09B USD
S&P 500 INDEX SPX 4594.63 USD
2.54B USD 4554.71 USD 4599.39 USD 2.54B USD
S&P 500 (Yahoo.com) GSPC 4594.63 USD
2.51B USD 4554.71 USD 4599.39 USD 2.51B USD
S&P 100 SP100 2159.78 USD
1.23B USD 2144.1 USD 2162.63 USD 1.23B USD
US100 NDX 15997.58 USD
882.88M USD 15834.93 USD 16013.75 USD 882.88M USD
Dow Jones U.S. Biotechnology In DJUSBT 2512.8 USD
90.98M USD 2482.71 USD 2512.89 USD 90.98M USD
NASDAQ-100 PM Settlement Value XQC 16331.98 USD
16331.98 USD 16331.98 USD
NASDAQ-100 Reduced Value Index NQX 3199.52 USD
3167.01 USD 3202.75 USD
NASDAQ 100 Notional Net Total R XNDXNNR 18390.99 USD
18204.01 USD 18409.58 USD
NASDAQ Global Select Market Com NQGS 6955.22 USD
6876.91 USD 6959.82 USD
Better Investing 100 BIXX 245.36 USD
Nasdaq-100 Micro Index XND 159.98 USD
158.35 USD 160.14 USD
NASDAQ DM Ex Japan Large Mid Ca NQDMXJPLMAUD 2100.38 AUD 1402.5 USD
2100.38 AUD 1402.5 USD 2100.38 AUD 1402.5 USD
The Capital Strength Net Total NQCAPSTN 3296.08 USD
3272.34 USD 3297.15 USD
NASDAQ 100 Ex Tech Sector NDXX 4978.26 USD
4892.33 USD 4979.63 USD